Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference
March 14 2018 - 4:01PM
Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T.
Isaacs, chairman, president and chief executive officer of Aduro,
will present at the 28th Annual Oppenheimer Healthcare Conference
in New York, NY on Wednesday, March 21, 2018, at 9:10 am Eastern
Time.
To access the live webcast and subsequent archived recording of
this and other company presentations, please visit Aduro's website
at www.aduro.com.
About Aduro Aduro Biotech, Inc. is an
immunotherapy company focused on the discovery, development and
commercialization of therapies that transform the treatment of
challenging diseases. Aduro's technology platforms, which are
designed to harness the body's natural immune system, are being
investigated in cancer indications and have the potential to expand
into autoimmune and infectious diseases. Aduro's STING Pathway
Activator platform is designed to activate the STING receptor in
immune cells, resulting in a potent tumor-specific immune response.
ADU-S100 is the first STING Pathway Activator compound to enter the
clinic and is currently being evaluated in both a Phase 1
monotherapy study as well as a Phase 1b combination study with an
anti-PD1 immune checkpoint inhibitor. Aduro’s B-select monoclonal
antibody platform is comprised of a number of immune modulating
assets in research and development, including BION-1301, an
anti-APRIL antibody. Aduro's pLADD program is based on proprietary
attenuated strains of Listeria that have been engineered to express
tumor neoantigens that are specific to an individual patient’s
tumor. Other Listeria strains for lung and prostate cancers are
being advanced by a partner. Aduro is collaborating with leading
global pharmaceutical companies to expand its products and
technology platforms. For more information, please visit
www.aduro.com.
Contact:
Jennifer Lew
Chief
Financial Officer
510
809-4816
Media Contact: Aljanae Reynolds510 809 2452
press@aduro.com
Aduro Biotech (NASDAQ:ADRO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aduro Biotech (NASDAQ:ADRO)
Historical Stock Chart
From Jul 2023 to Jul 2024